Lotta Larsson

742 total citations
9 papers, 597 citations indexed

About

Lotta Larsson is a scholar working on Rheumatology, Health, Toxicology and Mutagenesis and Epidemiology. According to data from OpenAlex, Lotta Larsson has authored 9 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Rheumatology, 2 papers in Health, Toxicology and Mutagenesis and 2 papers in Epidemiology. Recurrent topics in Lotta Larsson's work include Rheumatoid Arthritis Research and Therapies (4 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and Systemic Lupus Erythematosus Research (2 papers). Lotta Larsson is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (4 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and Systemic Lupus Erythematosus Research (2 papers). Lotta Larsson collaborates with scholars based in Sweden, Denmark and South Africa. Lotta Larsson's co-authors include Meliha C Kapetanovic, Tore Saxne, Pierre Geborek, Klaus Bendtzen, Morten Svenson, Per Ola Darnerud, Marie Aune, Dick Heinegård, Bengt Månsson and Lennart Truedsson and has published in prestigious journals such as The Science of The Total Environment, Chemosphere and Arthritis Research & Therapy.

In The Last Decade

Lotta Larsson

9 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lotta Larsson Sweden 7 225 213 127 120 86 9 597
Berenice Hernández-Castro Mexico 10 300 1.3× 407 1.9× 74 0.6× 98 0.8× 53 0.6× 18 754
Emi H. Kato Japan 21 152 0.7× 528 2.5× 180 1.4× 21 0.2× 39 0.5× 48 1.2k
Pascal H P de Jong Netherlands 16 576 2.6× 208 1.0× 43 0.3× 63 0.5× 126 1.5× 80 852
K Pile United Kingdom 11 287 1.3× 289 1.4× 36 0.3× 57 0.5× 21 0.2× 14 684
Peter DeGuire United States 5 351 1.6× 195 0.9× 128 1.0× 52 0.4× 7 0.1× 6 561
A Studnicka-Benke Austria 9 393 1.7× 280 1.3× 19 0.1× 92 0.8× 18 0.2× 15 606
Sarah Rogers United States 12 218 1.0× 323 1.5× 65 0.5× 16 0.1× 9 0.1× 20 933
Lixian Sun United States 16 101 0.4× 91 0.4× 47 0.4× 11 0.1× 68 0.8× 23 908
Richard J. Mier United States 12 167 0.7× 58 0.3× 55 0.4× 14 0.1× 53 0.6× 20 516
Antje Müller Germany 12 83 0.4× 169 0.8× 122 1.0× 14 0.1× 28 0.3× 26 477

Countries citing papers authored by Lotta Larsson

Since Specialization
Citations

This map shows the geographic impact of Lotta Larsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lotta Larsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lotta Larsson more than expected).

Fields of papers citing papers by Lotta Larsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lotta Larsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lotta Larsson. The network helps show where Lotta Larsson may publish in the future.

Co-authorship network of co-authors of Lotta Larsson

This figure shows the co-authorship network connecting the top 25 collaborators of Lotta Larsson. A scholar is included among the top collaborators of Lotta Larsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lotta Larsson. Lotta Larsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Larsson, Lotta, et al.. (2021). The physical and mental impact of surviving sepsis – a qualitative study of experiences and perceptions among a Swedish sample. Archives of Public Health. 79(1). 66–66. 18 indexed citations
2.
Claesson, Ing‐Marie, et al.. (2018). “You just need to leave the room when you breastfeed” Breastfeeding experiences among obese women in Sweden – A qualitative study. BMC Pregnancy and Childbirth. 18(1). 39–39. 21 indexed citations
3.
Fridberg, Torben, et al.. (2015). Adult Skills in the Nordic Region. Nordic Council of Ministers eBooks. 3 indexed citations
4.
Darnerud, Per Ola, Marie Aune, Lotta Larsson, et al.. (2011). Levels of brominated flame retardants and other pesistent organic pollutants in breast milk samples from Limpopo province, South Africa. The Science of The Total Environment. 409(19). 4048–4053. 56 indexed citations
5.
Darnerud, Per Ola, et al.. (2007). Plasma PBDE and thyroxine levels in rats exposed to Bromkal or BDE-47. Chemosphere. 67(9). S386–S392. 74 indexed citations
6.
Bendtzen, Klaus, Pierre Geborek, Morten Svenson, et al.. (2007). [Treatment of rheumatoid arthritis (RA) with anti-TNF-alpha antibody (Remicade). Individual monitoring of bioavailability and immunogenicity--secondary publication].. PubMed. 169(5). 420–3. 2 indexed citations
7.
Bendtzen, Klaus, Pierre Geborek, Morten Svenson, et al.. (2006). Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor α inhibitor infliximab. Arthritis & Rheumatism. 54(12). 3782–3789. 309 indexed citations
8.
Kapetanovic, Meliha C, Lotta Larsson, Lennart Truedsson, et al.. (2006). Predictors of infusion reactions during infliximab treatment in patients with arthritis. Arthritis Research & Therapy. 8(4). R131–R131. 48 indexed citations
9.
Kapetanovic, Meliha C, Bengt Månsson, Lotta Larsson, et al.. (2003). Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept. Arthritis Research & Therapy. 5(4). R181–5. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026